Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMay 11, 2022Lansoprazole Delayed-Release Orally Disintegrating TabletsFailed Dissolution SpecificationsDr. Reddy's Laboratories, Inc. · D-0853-2022Class IITerminatedMay 11, 2022Pantoprazole Sodium Delayed-Release TabletsCGMP deviations: tablets crackingTorrent Pharma Inc · D-0852-2022Class IIOngoingMay 11, 2022Erythromycin Topical Gel USPCGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.McKesson Corporation dba McKesson Drug Company · D-0851-2022Class IIOngoingMay 11, 2022Betamethasone Dipropionate Ointment USPCGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.McKesson Corporation dba McKesson Drug Company · D-0850-2022Class IIOngoingMay 11, 2022Lidocaine Prilocaine Cream USPCGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.McKesson Corporation dba McKesson Drug Company · D-0849-2022Class IIOngoingMay 11, 2022Lidocaine Hydrochloride Topical Solution USP 4%CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.McKesson Corporation dba McKesson Drug Company · D-0848-2022Class IIOngoingMay 11, 2022Halobetasol Propionate Ointment 0.05% Net WtCGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.McKesson Corporation dba McKesson Drug Company · D-0847-2022Class IIITerminatedMay 11, 2022Lidocaine Hydrochloride Oral Topical SolutionFailed viscosity specification - product was below specificcationAkorn, Inc. · D-0846-2022Class IITerminatedMay 11, 2022alprazolam XR extended-release tabletsFailed Dissolution Specifications: low out-of-specification dissolution test results observed.Viatris Inc · D-0844-2022Class IITerminatedMay 11, 2022Losartan Potassium and Hydrochlorothiazide Tablets USPCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsLupin Pharmaceuticals Inc. · D-0843-2022Class IITerminatedMay 11, 2022Losartan Potassium and Hydrochlorothiazide Tablets USPCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsLupin Pharmaceuticals Inc. · D-0842-2022Class IITerminatedMay 11, 2022Losartan Potassium and Hydrochlorothiazide Tablets USPCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsLupin Pharmaceuticals Inc. · D-0841-2022Class IITerminatedMay 11, 2022Losartan Potassium Tablets USPCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsLupin Pharmaceuticals Inc. · D-0840-2022Class IITerminatedMay 11, 2022Losartan Potassium Tablets USPCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsLupin Pharmaceuticals Inc. · D-0839-2022Class IITerminatedMay 11, 2022Losartan Potassium Tablets USPCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsLupin Pharmaceuticals Inc. · D-0838-2022Class IITerminatedMay 11, 2022Losartan Potassium & Hydrochlorothiazide TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-0837-2022Class IITerminatedMay 11, 2022Losartan Potassium & Hydrochlorothiazide TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-0836-2022Class IITerminatedMay 11, 2022Losartan Potassium & Hydrochlorothiazide TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-0835-2022Class IITerminatedMay 11, 2022Losartan Potassium TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-0834-2022Class IITerminatedMay 11, 2022Losartan Potassium TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-0833-2022Class IITerminatedMay 11, 2022Losartan Potassium TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsMacleods Pharma Usa Inc · D-0832-2022Class IITerminatedMay 11, 2022Vancomycin HCl 1.5 g in 0.9% Sodium ChlorideCGMP DeviationsSCA Pharmaceuticals · D-0831-2022Class IITerminatedMay 11, 2022Fentanyl 2mcg/ml and Bupivacaine 0.125% in 0.9% Sodium Chloride 100 mL bagsCGMP DeviationsSCA Pharmaceuticals · D-0830-2022Class IITerminatedMay 11, 2022Norepinephrine 8mg in 0.9% Sodium Chloride 250 mL bagCGMP DeviationsSCA Pharmaceuticals · D-0829-2022Class ITerminatedMay 4, 2022Insulin GlargineLabeling: Missing label on the vialMylan Pharmaceuticals Inc · D-0845-2022Class IITerminatedMay 4, 2022NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitutionFailed Reconstitution timeOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0828-2022Class IITerminatedMay 4, 2022Sincalide. Lyophilized powder for reconstitution. 5 mcg per Multi-Dose vialCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0827-2022Class IITerminatedMay 4, 2022Hydroxocobalamin B12CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0826-2022Class IITerminatedMay 4, 2022UltratestCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0825-2022Class IITerminatedMay 4, 2022Testosterone Cypionate 200 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0824-2022Class IITerminatedMay 4, 2022Testosterone Cypionate 200 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0823-2022Class IITerminatedMay 4, 2022Phenylephrine 1 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0822-2022Class IITerminatedMay 4, 2022Formula F2CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0821-2022Class IITerminatedMay 4, 2022T-50, Papaverine 8 mg/mL . Phentolamine 0.29 mg/mL . Alprostadil 2.9 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0820-2022Class IITerminatedMay 4, 2022PGE-3, Alprostadil 150 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0819-2022Class IITerminatedMay 4, 2022PGE-2, Alprostadil 80 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0818-2022Class IITerminatedMay 4, 2022PGE-1, Alprostadil 40 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0817-2022Class IITerminatedMay 4, 2022FA, Papaverine 20 mg/mL . Phentolamine 2 mg/mL . Alprostadil 20 mcg/mL . Atropine 0.2 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0816-2022Class IITerminatedMay 4, 2022BIMIX-3, Papaverine 30 mg/mL . Phentolamine 3 mg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0815-2022Class IITerminatedMay 4, 2022RE-2, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 300 mcg/mLCGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigatedOlympia Compounding Pharmacy dba Olympia Pharmacy · D-0814-2022